금융 뉴스 허브
실시간 글로벌 금융 시장 뉴스 · 분석 · 인사이트
BREAKING주요 뉴스
Gold draws support from retreating USD; holds above $4,150 as traders await US CPI report
Gold (XAU/USD) ticks higher during the Asian session on Wednesday, holding above $4,150 as traders n...
EUR/USD Price Forecast: Gains ground near 1.1150, US CPI awaited
The Euro (EUR) extends its Tuesday’s strong recovery move to near 1.1210 against the US Dollar (USD)...
2 Reasons to Sell ENVA and 1 Stock to Buy Instead
Enova currently trades at $171.80 and has been a dream stock for shareholders. It’s returned 366% since May 2021, blowing past the S&P 500’s 75.6% gain. The company has also beaten the index over the ...
Canadian Dollar flat lines near 1.3700 amid hot US CPI inflation, US-Iran tensions
The USD/CAD pair trades on a flat note near 1.3695 during the early Asian trading hours on Wednesday. Traders continue to assess hot US inflation data and ongoing tensions in the Middle East. The US A ...
Stereotaxis expects annual revenue to surpass $40M with Q3 and Q4 above $10M as MAGiC and Synchrony ramp
TransAct targets $1M-$1.75M adjusted EBITDA in 2026 while pulling BOHA! software go-live into late Q2 or early Q3
Intellicheck expects 90%-91% GAAP gross margin while projecting positive full-year 2026 net income
SenesTech signals cash runway into Q3 2027 as it targets record revenues through direct e-commerce control
Nextpower outlines $3.8B-$4.1B FY27 revenue while investing $130M to expand power conversion
Western Midstream expects high end of $2.5B-$2.7B 2026 adjusted EBITDA guidance, backed by $1.6B Brazos deal
TELA outlines at least 8% 2026 revenue growth while guiding Q2 revenue to about $20.0M
Trump’s plan to discuss Taiwan arms sales with Xi rattles Asian allies
Negotiations with Beijing on weapons exports to Taipei would break long US precedent
US President Donald Trump says trade will be priority in summit with Xi, not Iran
US President Donald Trump said that he would prioritize trade discussions during his summit with Chinese President Xi Jinping and downplayed the amount of attention they would devote to the Iran war, ...
OptimizeRx forecasts $95M-$100M 2026 revenue while maintaining $21M-$25M adjusted EBITDA amid pharma MFN disruption